Search

Home > The Bio Report > Epirus Sees Opportunities for Biosimilars Outside U.S.
Podcast: The Bio Report
Episode:

Epirus Sees Opportunities for Biosimilars Outside U.S.

Category: Business
Duration: 00:17:33
Publish Date: 2014-08-21 11:01:59
Description: The regulatory pathway for biosimilars is still a work in progress at the U.S. Food and Drug Administration, but around the world the industry is growing as regulators have resolved issues that remain obstacles in the United States. We spoke to Amit Munshi, CEO of Epirus Biopharmaceuticals, about the opportunities in emerging and developed markets, his company’s strategic approach, and when we’ll see a vibrant biosimilars industry in the United States.
Total Play: 0

Some more Podcasts by Levine Media Group

600+ Episodes